Answer
Dexketoprofen trometamol reduces prostaglandin synthesis by inhibiting COX-1 and COX-2 activity in the cyclooxygenase pathway, inhibiting the conversion of arachidonic acid into the prostaglandin precursors PGG2 and PGH2.
Sources for this answer
- Keral 25 mg film-coated tabletsA. Menarini Farmaceutica Internazionale SRL · emc · SmPC §5.1 Pharmacodynamic properties · Version 12Document updated
Sources checked